---
title: "AMPH SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Amphastar Pharmaceuticals (AMPH), with links to the SEC filings."
url: "https://tradytics.com/research/AMPH/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=AMPH&v=stock-11994860"
---

# AMPH financial statements and SEC filings

## AMPH annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $719.89M | $140.40M | $98.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2024-12-31 | $731.97M | $205.42M | $159.52M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2023-12-31 | $644.39M | $196.99M | $137.54M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2022-12-31 | $498.99M | $107.50M | $91.39M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718425000008/0001297184-25-000008-index.htm) |
| 2021-12-31 | $437.77M | $69.89M | $62.12M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718424000009/0001297184-24-000009-index.htm) |
| 2020-12-31 | $349.85M | $10.95M | $1.40M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718423000019/0001297184-23-000019-index.htm) |

## AMPH annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.63B | $840.49M | $788.80M | [10-Q](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000053/0001297184-26-000053-index.htm) |
| 2024-12-31 | $1.58B | $845.17M | $732.30M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2023-12-31 | $1.51B | $873.49M | $639.42M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718425000008/0001297184-25-000008-index.htm) |
| 2022-12-31 | $741.99M | $213.33M | $528.66M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718424000009/0001297184-24-000009-index.htm) |
| 2021-12-31 | $671.53M | $226.01M | $445.52M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718423000019/0001297184-23-000019-index.htm) |
| 2020-12-31 | $631.24M | $182.51M | $448.72M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718422000007/0001297184-22-000007-index.htm) |

## AMPH annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $156.12M | -$34.88M | -$67.42M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2024-12-31 | $213.39M | -$41.04M | -$80.95M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2023-12-31 | $183.50M | -$38.17M | $454.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm) |
| 2022-12-31 | $89.18M | -$24.03M | -$26.44M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718425000008/0001297184-25-000008-index.htm) |
| 2021-12-31 | $97.99M | -$27.46M | -$37.02M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718424000009/0001297184-24-000009-index.htm) |
| 2020-12-31 | $57.27M | -$33.85M | -$2.25M | [10-K](https://www.sec.gov/Archives/edgar/data/1297184/000129718423000019/0001297184-23-000019-index.htm) |

- [AMPH stock research](https://tradytics.com/research/AMPH)
- [AMPH financial summary](https://tradytics.com/research/AMPH/financials)
- [Read the data without JavaScript](https://tradytics.com/research/AMPH/fundamentals?snapshot=1)
